Conventional ultrasound combined with contrast-enhanced ultrasound quantitative analysis for diagnosing lung cancer metastases in neck lymph nodes

Lung cancer remains one of the most common malignant tumors. Identifying cervical lymph node metastases is important to stage lung cancer, evaluate patients’ prognosis and select appropriate treatments. This study evaluated the utility of conventional ultrasound combined with contrast-enhanced ultrasound (CEUS) quantitative analysis in diagnosing lung cancer metastases in the lymph nodes of the neck. The cervical lymph nodes of 39 patients with primary lung cancer who underwent CEUS and ultrasound-guided needle biopsy were assessed. Routine type B ultrasound was used to record the morphology of the lymph nodes and the presence of lymphatic hilum structure. The Vuebox quantitative analysis software was used to collect lymph node CEUS peak enhancements (PE), rise time (RT) and fall time (FT). The receiver operating characteristic (ROC) curve was used to evaluate the diagnostic value of various parameters and imaging characteristics. The cohort comprised 26 cervical lymph nodes with lung cancer metastasis and 13 cervical lymph nodes with reactive hyperplasia. Most hilum of lymph gland were absent in the metastasis group (92.30%), most lymph nodes showed a full shape (80.77%), and few were irregularly shaped (19.23%). Most hilum of lymph gland were present in the hyperplasia group (76.95%) and showed a full shape (61.54%). The PE of the metastasis group (4852.29 a.u) was significantly lower than the hyperplasia group (11,464.70 a.u), while the difference between RT and FT indicators was not significant. ROC analysis showed that combined PE of the quantitative ultrasound contrast analysis and the presence of the lymphatic phylum structure showed satisfactory diagnostic ability for detecting lung cancer lymph node metastasis in the neck (sensitivity 73.10%, specificity 76.90%, accuracy 48.73%, p = 0.004). Conventional ultrasound observation of lymph node structure combined with quantitative analysis of peak enhancement of contrast-enhanced ultrasound showed promising value for diagnosing lung cancer metastatic lymph nodes.

Ultrasonography; CEUS; Quantitative analysis; Cervical lymph node; Metastatic lymph nodes

[1] Liu ZC, Li ZX, Zhang Y, Zhou T, Zhang JY, You WC, et al. Interpretation on the report of Global Cancer Statistics 2020. Journal of Multidisciplinary Cancer Management. 2021; 7: 1–14. (In Chinese)

[2] Khaltaev N, Axelrod S. Global lung cancer mortality trends and lifestyle modifications: preliminary analysis. Chinese Medical Journal. 2020; 133: 1526–1532.

[3] Ma TT, Wan YX, Shi L. Pathological characteristics and prognosis of patients with primary lung cancer. The Practical Journal of Cancer. 2019; 34: 1835–1838. (In Chinese)

[4] Xie X, Li X, Tang W, Xie P, Tan X. Primary tumor location in lung cancer: the evaluation and administration. Chinese Medical Journal. 2022; 135: 127–136.

[5] Chammas MC, Macedo TAA, Lo VW, Gomes AC, Juliano A, Cerri GG. Predicting malignant neck lymphadenopathy using color duplex sonogra-phy based on multivariate analysis. Journal of Clinical Ultrasound. 2016; 44: 587–594.

[6] Mei M, Ye L, Quan J, Huang P. Contrast-enhanced ultrasound for the differential diagnosis between benign and metastatic superficial lymph nodes: a meta-analysis. Cancer management and research. 2018; 10: 4987–4997.

[7] Liu HF, Xiao JD. Flow imaging of residual neck lymph nodes in nasopharyngeal carcinoma by contras-enhanced ultrasonography after radiotherapy. Journal of Central South University (Medical sciences). 2010; 35: 861–863. (In Chinese)

[8] Wang DL, Yang GY, Shao YQ, Zhang WZ. Contrast-enhanced ultrasound for research on tuberculosis of axillary lymph node. Journal of Medical Research. 2013; 42: 187–189.

[9] Giacomini CP, Jeffrey RB, Shin LK. Ultrasonographic evaluation of malignant and normal cervical lymph nodes. Seminars in Ultrasound, CT and MRI. 2013; 34: 236–247.

[10] Ying M, Bhatia KS, Lee YP, Yuen HY, Ahuja AT. Review of ultrasonography of malignant neck nodes: greyscale, Doppler, contrast enhancement and elastography. Cancer Imaging. 2014; 13: 658–669.

[11] Bialek EJ, Jakubowski W, Szczepanik AB, Maryniak RK, Prochorec-Sobieszek M, Bilski R, et al. Vascular patterns in superficial lymphoma-tous lymph nodes: a detailed sonographic analysis. Journal of Ultrasound. 2007; 10: 128–134.

[12] Liu Y, Chen J, Zhang C, Li Q, Zhou H, Zeng Y, et al. Ultrasound-based radiomics can classify the etiology of cervical lymphadenopathy: a multi-center retrospective study. Frontiers in Oncology. 2022; 12: 856605.

[13] Sidhu PS, Cantisani V, Dietrich CF, Gilja OH, Saftoiu A, Bartels E, et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version). Ultraschall in der Medizin. 2018; 39: e2–e44.

[14] Dudau C, Hameed S, Gibson D, Muthu S, Sandison A, Eckersley RJ, et al. Can contrast-enhanced ultrasound distinguish malignant from reactive lymph nodes in patients with head and neck cancers? Ultrasound in Medicine & Biology. 2014; 40: 747–754.

[15] Weskott HP. Contrast-enhanced ultrasound in the diagnostic workup of lymph nodes. Radiologe. 2018; 58: 563–571. (In German)

[16] Xin L, Yan Z, Zhang X, Zang Y, Ding Z, Xue H, et al. Parameters for contrast-enhanced ultrasound (CEUS) of enlarged superficial lymph nodes for the evaluation of therapeutic response in lymphoma: a preliminary study. Medical Science Monitor. 2017; 23: 5430–5438.

[17] Yin S, Cui Q, Fan Z, Yang W, Yan K. Diagnostic value of arrival time parametric imaging using contrast-enhanced ultrasonography in superficial enlarged lymph nodes. Journal of Ultrasound in Medicine. 2019; 38: 1287–1298.

[18] Nie J, Ling W, Yang Q, Jin H, Ou X, Ma X. The value of CEUS in distinguishing cancerous lymph nodes from the primary lymphoma of the head and neck. Frontiers in Oncology. 2020; 10: 473.

[19] Schwarz S, Clevert DA, Ingrisch M, Geyer T, Schwarze V, Rübenthaler J, et al. Quantitative analysis of the time-intensity curve of contrast-enhanced ultrasound of the liver: differentiation of benign and malignant liver lesions. Diagnostics. 2021; 11: 1244.

[20] Lu Q, Zhang X, Han H, Huang B, Ding H, Wang W. Value of perfusion parameters for differentiating hepatocellular carcinoma and liver metastasis with hypervascularity and a normal hepatic background on contrast-enhanced ultrasound imaging. Journal of Ultrasound in Medicine. 2019; 38: 2601–2608.

[21] Lerchbaumer MH, Wakonig KM, Arens P, Dommerich S, Fischer T. Quantitative multiparametric ultrasound (mpUS) in the assessment of inconclusive cervical lymph nodes. Cancers. 2022; 14: 1597.